Breast density, which is associated with breast cancer risk, is higher in black/African-American women than in white women, according to research presented at the AACR Annual Meeting.
Anne Marie McCarthy, PhD
Breast density, which is associated with breast cancer risk, is higher in black/African-American women than in white women, according to research presented at the AACR Annual Meeting.
The study enrolled 1589 black women and 1256 white women who underwent screening mammography at the University of Pennsylvania from 2010 to 2011. The researchers found that black women in the study had a significantly higher absolute area density of 40.1 cm2 compared with 33.1 cm2 in white women. The study also showed that black women had a significantly higher volumetric density of 187.2 cm3 compared with 181.6 cm3 in white women.
“Since breast density is associated with breast cancer risk, a better understanding of racial differences in breast density levels could help us identify women at the highest risk for breast cancer and target prevention strategies to those women,” Anne Marie McCarthy, PhD, a research fellow at Massachusetts General Hospital and lead author of the study, said in a statement.
Breast density refers to the amount of fibroglandular tissue in the breast when observed on a mammogram. Since the fibroglandular tissue appears as white on the mammogram, it makes it difficult to visually detect breast cancers.
Research has shown that women who have the highest breast density have a 4 to 6 times greater risk for breast cancer compared with women with lower breast density.
Although several studies have previously shown that black women have lower breast density than white women on average, the authors of this study suggest the reason behind that may be partly due to racial differences in BMI, which is inversely associated with density.
Usually, radiologists examine mammograms and assign patients a breast density level, but that assignment can be subjective, McCarthy explained. For this study, which was funded by the National Institutes of Health, the researchers used fully automated, computer algorithms to produce both the conventional two-dimensional breast density measurement and a three-dimensional volumetric estimate of breast density.
“Our findings are using a new, quantitative and, perhaps, more reliable way to measure breast density,” McCarthy said.
The mean age of the patients was 57. The results showed that black women had higher mean BMI and higher absolute area and volume density than white women but lower area and volume percent density.
When adjusting for age, BMI, and breast cancer risk factors, black women had higher breast density across all measures. The results also showed that the interaction between race and BMI was significant for area percent and volume percent density and was near significant for volume density; however, for all three measures, BMI was more strongly associated with density among white women than black women.
The researchers concluded that the significantly higher breast density in black women was not explained by BMI or recognized breast cancer risk. Therefore, racial differences in breast density may have implications for disease risk and prevention strategies.
Follow-up ultrasound screening for women with dense breasts continues to garner interest among advocates and researchers, with 22 states enacting breast density reporting laws and legislation pending in the US Congress. A study presented at the 2014 San Antonio Breast Cancer Symposium drawing on data from radiology practices in Connecticut (the first state to enact legislation mandating breast density reporting) showed that during 4 years of ultrasound screening of mammographically normal but dense breasts, the follow-up screening did detect a significant number of breast cancers not discovered by mammogram.2
“Our next step will be to see how quantitative density measures and other imaging biomarkers are associated with cancer risk, cancer subtype, and stage of diagnosis by race,” McCarthy said.
References
Nurse Practitioners Weigh in on Data From the San Antonio Breast Cancer Symposium
January 16th 2023Loyda Braithwaite, MSN, RN, AGPCNP-BC, AOCNP; and Jamie Carroll, APRN, CNP, MSN, highlight presentations from the 2022 San Antonio Breast Cancer Symposium that will influence oncology nursing practice.